Pharma Journalist -

Ahead of the 7th Annual IMPACCT: Real World Evidence, Sandy Leonard, former VP, Medical Evidence & Observational Research at AstraZeneca has taken some time to let us know her…
Read More...

Merck, a leading science and technology company, announced the signing of a non-binding Memorandum of Understanding (MoU) with Phanes Therapeutics, Inc. (Phanes) for a collaboration on…
Read More...

Lonza announced the start of expansion to its bioconjugation facility in Visp, Switzerland together with the successful commercial approval of a third antibody-drug-conjugate (ADC)…
Read More...

Zambon, a multinational pharmaceutical company that focuses on innovation and development with the aim to improve the quality of people’s health and patients’ lives, announces the…
Read More...

Epizyme, Inc. announced that the U.S. Food and Drug Administration (FDA) has accepted for filing the company’s New Drug Application (NDA) for accelerated approval of tazemetostat, its…
Read More...

Aucta Pharmaceuticals, Inc. (Aucta), a technology based company focusing on the development and commercialization of Branded Specialty Products, announced that the Company has entered…
Read More...

BioCardia, Inc. announced it has signed an extension to a 2017 development agreement with AstraZeneca for BioCardia’s Helix biotherapeutic delivery catheter system. Under the terms…
Read More...

Valneva SE, a biotech company developing and commercializing vaccines for infectious diseases with major unmet needs, and the Coalition for Epidemic Preparedness Innovations (CEPI)…
Read More...

Gemphire Therapeutics Inc., a clinical-stage biopharmaceutical company focused on developing therapies for the treatment of dyslipidemia as well as nonalcoholic fatty liver disease, and…
Read More...

Opiant Pharmaceuticals, Inc. announced that it has signed an agreement with Sanofi to manufacture Opiant’s investigational agent OPNTOO4 (drinabant) for the treatment of Acute…
Read More...